Microglial Neuroprotection and Neurotoxicity
小胶质细胞的神经保护和神经毒性
基本信息
- 批准号:6611806
- 负责人:
- 金额:$ 39.86万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-09-01 至 2008-03-31
- 项目状态:已结题
- 来源:
- 关键词:Alzheimer's disease amyloid proteins biological signal transduction colony stimulating factor enzyme linked immunosorbent assay gene expression immunocytochemistry laboratory rat laser capture microdissection microglia mixed tissue /cell culture neurons neuroprotectants neurotoxicology nitric oxide polymerase chain reaction transfection
项目摘要
DESCRIPTION (provided by applicant): Macrophage colony stimulating factor (M-CSF) is a microglial activator that is important in the cerebral inflammatory response. M-CSF expression is increased in AD and in the PDAPP transgenic mouse model for AD. The M-CSF receptor (M-CSFR) is increased on microglia in AD, in the PDAPP mouse, and in experimental models for brain injury. Overexpression of M-CSFR on microglia results in proliferation, increased expression of cytokines, and paracrine activation of other inflammatory cells. M-CSFR overexpression also results in aggressive microglial phagocytosis of Abeta by both FcgammaR-dependent and - independent mechanisms. Surprisingly, overexpression of M-CSFR on microglia protects neurons from excitotoxic injury in slice cultures transfected using biolistics, and in a microglial-hippocampal organotypic co-culture system. Also, M-CSF protects neurons in organotypic cultures from excitotoxic injury. In the proposed experiments, M-CSFR-induced microglial expression of potentially protective neurotrophins, cytokines, chemokines, and nitric oxide will be quantified after NMDA treatment in the biolistic transfection model and in the co-culture system. To localize differential expression to individual cell types, immunohistochemistry and laser capture microdissection will be used to obtain homogeneous populations of cells from slice cultures for real-time RT-PCR. To identify neuroprotective factors, hammerhead ribozymes will be used to block microglial expression and antibodies will be used to neutralize microglial factors in the co-culture. Candidate neuroprotective factors will also be tested for rescue of neurons from NMDA toxicity by adding them to organotypic culture medium. The signal transduction pathways activated by the M-CSFR that affect proliferation, cytokine expression, and phagocytosis are unknown. Hence, experiments will be performed to test activation of microglial Src kinases, PI3K, and Ras-mediated signaling, all of which are important in M-CSFR signal transduction in other cell types. These studies will define how activation of microglial M-CSFR protects neurons, and identify the molecular mechanisms by which the M-CSFR activates microglia and induces Abeta phagocytosis. Understanding the functions of M-CSFR and its ligand in microglia may lead to new strategies to promote Abeta clearance and to protect neurons in AD and other brain disorders. Much emphasis has been placed on the negative role of microglia. Although microglial neurotoxicity undoubtedly occurs in many disease states, it is important to understand how microglia might be induced to clear abnormal proteins from the brain or provide neuroprotection.
描述(由申请人提供):巨噬细胞刺激因子(M-CSF)是一种小胶质激活因子,在脑炎症反应中很重要。在AD和AD的PDAPP转基因小鼠模型中,M-CSF表达增加。在AD,PDAPP小鼠中的小胶质细胞和脑损伤的实验模型中,M-CSF受体(M-CSFR)增加。 M-CSFR对小胶质细胞的过表达导致其他炎症细胞的增殖,细胞因子的表达增加以及旁分泌激活。 M-CSFR的过表达还会导致通过FCGAMMAR依赖性和 - 独立机制对Abeta的侵袭性小胶质细胞增多症。出乎意料的是,M-CSFR对小胶质细胞的过表达可保护神经元在使用生物学转染和小胶质细胞器官型共培养系统中转染的切片培养物中的兴奋性毒性损伤。此外,M-CSF可保护器官培养基中的神经元免受兴奋性毒性损伤。在提出的实验中,M-CSFR诱导的小胶质细胞表达在NMDA处理后,将在生物学转染模型和共培养系统中对NMDA处理后进行定量的潜在保护性神经营养蛋白,细胞因子,趋化因子和一氧化氮。为了将差异表达定位到单个细胞类型中,免疫组织化学和激光捕获显微解剖将用于从Slice培养物中获取用于实时RT-PCR的细胞的均匀种群。为了鉴定神经保护因素,将使用锤头核酶来阻断小胶质细胞表达,抗体将用于中和共培养中的小胶质细胞因子。候选神经保护因素还将通过将其添加到器官培养基中,以从NMDA毒性中拯救神经元。由M-CSFR激活的信号转导途径影响增殖,细胞因子表达和吞噬作用是未知的。因此,将进行实验以测试小胶质细胞SRC激酶,PI3K和RAS介导的信号传导的激活,所有这些信号在其他细胞类型中都很重要。这些研究将定义小胶质细胞M-CSFR的激活如何保护神经元,并确定M-CSFR激活小胶质细胞并诱导Abeta吞噬作用的分子机制。了解M-CSFR及其在小胶质细胞中的配体的功能可能会导致新的策略来促进ABETA清除并保护AD和其他脑部疾病中的神经元。非常重视小胶质细胞的负面作用。尽管小胶质细胞神经毒性无疑是在许多疾病状态发生的,但重要的是要了解如何诱导小胶质细胞清除大脑的异常蛋白质或提供神经保护作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GREER M MURPHY其他文献
GREER M MURPHY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GREER M MURPHY', 18)}}的其他基金
Pharmacogenetics of the Antidepressant Response in Geriatric Major Depression
老年重度抑郁症抗抑郁反应的药物遗传学
- 批准号:
8032654 - 财政年份:2010
- 资助金额:
$ 39.86万 - 项目类别:
Pharmacogenetics of the Antidepressant Response in Geriatric Major Depression
老年重度抑郁症抗抑郁反应的药物遗传学
- 批准号:
7269493 - 财政年份:2006
- 资助金额:
$ 39.86万 - 项目类别:
Pharmacogenetics of the Antidepressant Response in Geriatric Major Depression
老年重度抑郁症抗抑郁反应的药物遗传学
- 批准号:
7892494 - 财政年份:2006
- 资助金额:
$ 39.86万 - 项目类别:
Pharmacogenetics of the Antidepressant Response in Geriatric Major Depression
老年重度抑郁症抗抑郁反应的药物遗传学
- 批准号:
7486315 - 财政年份:2006
- 资助金额:
$ 39.86万 - 项目类别:
Pharmacogenetics of the Antidepressant Response in Geriatric Major Depression
老年重度抑郁症抗抑郁反应的药物遗传学
- 批准号:
7145228 - 财政年份:2006
- 资助金额:
$ 39.86万 - 项目类别:
Pharmacogenetics of the Antidepressant Response in Geriatric Major Depression
老年重度抑郁症抗抑郁反应的药物遗传学
- 批准号:
7670264 - 财政年份:2006
- 资助金额:
$ 39.86万 - 项目类别:
相似国自然基金
釉原蛋白丝带状组装体的淀粉样组装行为及其生物学功能特性研究
- 批准号:32301042
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
桑椹糖肽靶向Cyclophilin D抑制淀粉样蛋白产生和线粒体功能障碍干预阿尔茨海默病的作用机制
- 批准号:82374059
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
阿尔茨海默病中β-淀粉样蛋白在脑血管沉积的机制与干预研究
- 批准号:82371418
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
淀粉样蛋白在仿生物膜界面的寡聚化研究
- 批准号:22375122
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
淀粉样前体蛋白基因异常损伤细胞膜铁转运启动早发型阿尔茨海默病的新机制及其干预策略研究
- 批准号:82371195
- 批准年份:2023
- 资助金额:47 万元
- 项目类别:面上项目
相似海外基金
Atlas for neuronal and glial cell types selectively vulnerable to proteinopathies during progression of Alzheimer's Disease
在阿尔茨海默病进展过程中选择性易受蛋白质病影响的神经元和神经胶质细胞类型图谱
- 批准号:
10667245 - 财政年份:2023
- 资助金额:
$ 39.86万 - 项目类别:
Uncovering the Role of the MS4A Gene Family in Alzheimer's Disease
揭示 MS4A 基因家族在阿尔茨海默病中的作用
- 批准号:
10751885 - 财政年份:2023
- 资助金额:
$ 39.86万 - 项目类别:
The Alzheimer's Disease Tau Platform Clinical Trial
阿尔茨海默病 Tau 平台临床试验
- 批准号:
10655872 - 财政年份:2023
- 资助金额:
$ 39.86万 - 项目类别:
Brain glycosphingolipids and Alzheimer's disease
脑鞘糖脂与阿尔茨海默病
- 批准号:
10738379 - 财政年份:2023
- 资助金额:
$ 39.86万 - 项目类别:
Diagnostic aptamer reagents to develop multi-analyte blood test for pre-clinical, mild and moderate Alzheimer's disease
诊断适体试剂用于开发针对临床前、轻度和中度阿尔茨海默病的多分析物血液检测
- 批准号:
10597840 - 财政年份:2023
- 资助金额:
$ 39.86万 - 项目类别: